Results 131 to 140 of about 46,038 (143)

Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial

Lancet, The, 2002
Juergen Braun, W Golder, H Sorensen
exaly  

Infliximab

Reactions Weekly, 2020
openaire   +1 more source

Efficacy and safety of biosimilar CT-P13 compared with originator infliximab in patients with active Crohn's disease: an international, randomised, double-blind, phase 3 non-inferiority study

Lancet, The, 2019
Houng Kim, Chang Soo Eun, Byong Duk Ye
exaly  

Long-term Infliximab Maintenance Therapy for Ulcerative Colitis: The ACT-1 and -2 Extension Studies

Inflammatory Bowel Diseases, 2012
Bruce Sands, Jean Fred Colombel
exaly  

Influence of methotrexate on infliximab pharmacokinetics and pharmacodynamics in ankylosing spondylitis

British Journal of Clinical Pharmacology, 2012
Daniel Wendling, Gilles Paintaud, David Ternant   +2 more
exaly  

Infliximab for the treatment of active scleritis

Canadian Journal of Ophthalmology, 2009
H Nida Sen, Grace A Levy-Clarke
exaly  

Incidence and importance of antibody responses to infliximab after maintenance or episodic treatment in Crohn’s disease

Clinical Gastroenterology and Hepatology, 2004
Stephen Hanauer, Suzanne Travers, Allan Olson   +2 more
exaly  

Pattern of infliximab utilization in rheumatoid arthritis patients at an academic medical center

Arthritis and Rheumatism, 2005
Michael Weinblatt, Lori Chibnik, Sandeep Agarwal   +2 more
exaly  

A clinical study assessing the tolerability and biological effects of infliximab, a TNF-α inhibitor, in patients with advanced cancer

Annals of Oncology, 2008
D Propper, J F Smyth, F R Balkwill
exaly  

Infliximab

Reactions Weekly
openaire   +2 more sources